FPF Workshop 2018: Perspectives on the FCM safety

Afternoon session of FPF Workshop 2018 discusses different approaches to ensuring FCM safety taken by industry, government, retailers, consumer organizations

FPF Workshop 2018: Improving chemical safety by new science

Presentations at Food Packaging Forum 2018 workshop cover predictive toxicology, computational methodologies, green chemistry

FPF Workshop 2018: Assessing the safety of food packaging

Experts identify challenges for risk assessment and management of food contact chemicals, present toxicity tests and analytical tools for safer food packaging

Ames test insufficient for genotoxicity of FCMs

Scientists deem Ames test unsuitable as standalone method to evaluate genotoxicity of FCM migrates, suggest complementing it with chemical information

CLARITY-BPA update

U.S. National Toxicology Program publishes final report on CLARITY-BPA core study and releases primary data from academic studies; joint report integrating findings from both research lines expected in fall 2019

FCM analysis at BioDetectors conference 2018

11th BioDetectors conference addresses use of cell-based bioassays in food contact material safety analysis

Human health impacts of dietary BPA exposure

Scientists review sources and levels of dietary exposure to bisphenol A, discuss health risks in exposed populations, call for targeted risk assessments in sensitive populations such as pregnant women and children

BPA substitutes and chromosomal abnormalities

Mice exposed to low doses of BPA, BPS, diphenyl sulfone, BPF, BPAF exhibit chromosomal abnormalities that persist for several generations, according to new study in Current Biology

CLARITY-BPA webinars: Key messages

Carnegie Mellon University and FDA hold webinars on CLARITY-BPA academic research and guideline studies; FDA upholds importance of high-dose effects; academic researchers highlight significant low-dose effects

BPA human study: Effects on insulin response

First experimental study in humans finds low-dose exposure to bisphenol A alters insulin response to oral and IV glucose, possibly increases diabetes 2 risk